Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression

Cancer Science

Volumn 101, Issue 3, 2010, Pages 666-672

  Effendi, Kathryn ^a   Mori, Taisuke ^a   Komuta, Mina ^a   Masugi, Yohei ^a   Du, Wenlin ^a   Sakamoto, Michiie ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NEOPLASM STAGING; NUCLEAR PROTEINS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 77949637537     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01431.x     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991, 22:172-8.
3. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-11.
4. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
5. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991, 65:737-52.
6. Mori T, Kiyono T, Imabayashi H. Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol Cell Biol 2005, 25:5183-95.
7. Haga K, Ohno S, Yugawa T. Efficient immortalization of primary human cells by p16INK4a-specific short hairpin RNA or Bmi-1, combined with introduction of hTERT. Cancer Sci 2007, 98:147-54.
8. Dimri GP, Martinez JL, Jacobs JJ. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res 2002, 62:4736-45.
9. Song LB, Zeng MS, Liao WT. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66:6225-32.
10. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999, 397:164-8.
11. Jacobs JJ, Scheijen B, Voncken JW, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999, 13:2678-90.
12. van Kemenade FJ, Raaphorst FM, Blokzijl T. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001, 97:3896-3901.
13. Bea S, Tort F, Pinyol M. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001, 61:2409-12.
14. Vonlanthen S, Heighway J, Altermatt HJ. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001, 84:1372-6.
15. Kim JH, Yoon SY, Kim CN. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett 2004, 203:217-24.
16. Qin ZK, Yang JA, Ye YL. Expression of Bmi-1 is a prognostic marker in bladder cancer. BMC Cancer 2009, 9:61.
17. Wang H, Pan K, Zhang HK. Increased polycomb-group oncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma. J Cancer Res Clin Oncol 2008, 134:535-41.
18. Sasaki M, Ikeda H, Itatsu K. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma. Lab Invest 2008, 88:873-82.
19. Hui AM, Sakamoto M, Kanai Y. Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology 1996, 24:575-9.
20. Kaneto H, Sasaki S, Yamamoto H. Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut 2001, 48:372-7.
21. Genda T, Sakamoto M, Ichida T. Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 1999, 30:1027-36.
22. Hirohashi S, Ishak K, Kojiro M. Tumours of the liver and intrahepatic bile ducts. Pathology and Genetics of Tumours of the Digestive System 2000, 157-202. Hamilton SR, Aaltonen LA, In, eds, Lyon, IARC Press
23. Neo SY, Leow CK, Vega VB. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 2004, 39:944-53.
24. Francis NJ, Kingston RE. Mechanisms of transcriptional memory. Nat Rev Mol Cell Biol 2001, 2:409-21.
25. Buchenau P, Hodgson J, Strutt H, Arndt-Jovin DJ. The distribution of polycomb-group proteins during cell division and development in Drosophila embryos: impact on models for silencing. J Cell Biol 1998, 141:469-81.
26. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer: the polycomb connection. Cell 2004, 118:409-18.
27. Nagao K, Tomimatsu M, Endo H, Hisatomi H, Hikiji K. Telomerase reverse transcriptase mRNA expression and telomerase activity in hepatocellular carcinoma. J Gastroenterol 1999, 34:83-7.
28. Oh BK, Jo Chae K, Park C. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 2003, 39:786-92.
29. Molofsky AV, He S, Bydon M, Morrison SJ, Pardal R. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways. Genes Dev 2005, 19:1432-7.
30. Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF, Morrison SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003, 425:962-7.
31. Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1985, 316:820-3.
32. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1985, 316:817-9.
33. Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP. Effects of retroviral-mediated MDR1 expression on hematopoietic stem cell self-renewal and differentiation in culture. Ann NY Acad Sci 1999, 872:125-40. discussion 40-1
34. Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002, 20:11-20.
35. Keshet GI, Goldstein I, Itzhaki O. MDR1 expression identifies human melanoma stem cells. Biochem Biophys Res Commun 2008, 368:930-6.
36. Vander Borght S, Komuta M, Libbrecht L. Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin. Liver Int 2008, 28:1370-80.